IGF1 and metabolic syndrome: In addition to elevated levels of circulating insulin and IGF-I, obesity and metabolic syndrome are associated with a low-grade, chronic (smoldering) state of inflammation characterized by increased circulating free fatty acids and the chemoattraction of immune cells, like macrophages, into the local adipose tissue milieu (174–176).